Q3 2023 Holdings
Filed 2023-11-03 | 8 holdings | $188.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| RayzeBio, Inc. | Common Stock | 75525N107 | $114.5M | 5,158,161 | 60.9% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $32.0M | 2,646,657 | 17.0% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $22.6M | 498,558 | 12.0% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $7.6M | 5,068,233 | 4.0% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $6.1M | 3,561,150 | 3.3% |
| Passage Bio, Inc. | Common Stock | 702712100 | $3.3M | 4,959,769 | 1.7% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $1.7M | 2,320,381 | 0.9% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $275.3K | 83,684 | 0.1% |